Aptamer-Modified Magnetic Nanoparticles as Targeted Drug Delivery Systems for Hepatocellular Carcinoma
<b>Background</b>: Hepatocellular carcinoma is associated with high mortality and increasing incidence. Sorafenib, a cornerstone of therapy for advanced hepatocellular carcinoma, presents certain disadvantages, including low bioavailability and poor water solubility. This work describes a new strate...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2025-10-01
|
| Serija: | Pharmaceutics |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1999-4923/17/10/1292 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
